Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Publication
, Journal Article
Khasraw, M; Robson, M
Published in: Clinical Investigation
November 2011
Duke Scholars
Published In
Clinical Investigation
DOI
EISSN
2041-6806
ISSN
2041-6792
Publication Date
November 2011
Volume
1
Issue
11
Start / End Page
1545 / 1554
Publisher
OMICS Publishing Group
Citation
APA
Chicago
ICMJE
MLA
NLM
Khasraw, M., & Robson, M. (2011). Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges. Clinical Investigation, 1(11), 1545–1554. https://doi.org/10.4155/cli.11.132
Khasraw, Mustafa, and Mark Robson. “Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges.” Clinical Investigation 1, no. 11 (November 2011): 1545–54. https://doi.org/10.4155/cli.11.132.
Khasraw M, Robson M. Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges. Clinical Investigation. 2011 Nov;1(11):1545–54.
Khasraw, Mustafa, and Mark Robson. “Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges.” Clinical Investigation, vol. 1, no. 11, OMICS Publishing Group, Nov. 2011, pp. 1545–54. Crossref, doi:10.4155/cli.11.132.
Khasraw M, Robson M. Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges. Clinical Investigation. OMICS Publishing Group; 2011 Nov;1(11):1545–1554.
Published In
Clinical Investigation
DOI
EISSN
2041-6806
ISSN
2041-6792
Publication Date
November 2011
Volume
1
Issue
11
Start / End Page
1545 / 1554
Publisher
OMICS Publishing Group